Fonar/FONR

$16.01

-1.17%
-
1D1W1MYTD1YMAX

About Fonar

FONAR Corporation is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging scanners, MRI, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company conducts its business in two segments. The medical equipment segment is conducted directly through FONAR. The physician management and diagnostic services segment is conducted through its subsidiary Health Management Corporation of America (HMCA). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing, information technology (IT) services, hiring, conducting interviews and managing personnel, storage of medical records, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging.

Ticker

FONR

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Timothy Damadian

Employees

561

Headquarters

Melville, United States

Fonar Metrics

BasicAdvanced
$108.7M
Market cap
9.29
P/E ratio
$1.74
EPS
1.19
Beta
-
Dividend rate
$108.7M
1.19481
$24.05
$12.13
20.52K
9.348
9.148
0.366
0.529
2.757
8.33%
7.65%
8.64%
9.291
1.061
0.663
0.695
8.924
5.78%
48.55%
4.8%
3.92%

Fonar Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
14.62% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$25.3M
-1.94%
Net income
$3.7M
-9.76%
Profit margin
14.62%
-7.99%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Fonar stock?

Fonar (FONR) has a market cap of $108.7M as of April 25, 2024.

What is the P/E ratio for Fonar stock?

The price to earnings (P/E) ratio for Fonar (FONR) stock is 9.29 as of April 25, 2024.

Does Fonar stock pay dividends?

No, Fonar (FONR) stock does not pay dividends to its shareholders as of April 25, 2024.

When is the next Fonar dividend payment date?

Fonar (FONR) stock does not pay dividends to its shareholders.

What is the beta indicator for Fonar?

Fonar (FONR) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Fonar stock price target?

The target price for Fonar (FONR) stock is $, which is 100% below the current price of $16.19. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Fonar stock

Buy or sell Fonar stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing